Tackling Science's Reproducibility Problem with Briefly Bio's Katya Putintseva

After a short break, I'm excited to bring you the 21st episode, where I’m joined by Katya Putintseva, co-founder of Briefly Bio. This London-based startup is using an AI-driven approach to tackle the reproducibility crisis in science—an issue with far-reaching consequences for both academia and industry. In this episode, we explore Katya's background, her entrepreneurial journey with Briefly Bio, and the innovative technology powering the company. We also dive into the broader mission and vision behind Briefly Bio, discussing AI's evolving role in research and the importance of open science. I hope you enjoy the episode!

00:00
Introduction to Katya Putintseva and Briefly Bio
03:09
The Challenges and Importance of Scientific Communication
05:48
The Goal of Briefly Bio
08:58
Standardization vs. Flexibility in Scientific Documentation
11:50
Target Users
15:11
The Importance of Open Science
18:06
Funding
21:00
AI's developing role in Biotech
23:57
Advice for Aspiring Entrepreneurs in Biotech